Security key
687604108
Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (ORKA)
CUSIP: 687604108
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 45,557,412
- Total 13F value
- $875,823,009
- Share change
- +11,125,433
- Put/Call ratio
- 552%
- SEC-reported price per share
- $19.23
- Number of holders
- 104
- Value change
- +$220,884,566
- Number of buys
- 61
- Number of sells
- 30
- Shares outstanding
- 50,314,906
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q3 2025
Institutions
104
Top holders
10
ORKA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Oruka Therapeutics, Inc. SEC filings
Oruka Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 687604108
Recent filing periods:
Ownership snapshot
Top reported holders of ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Largest current holder
Venrock Healthcare Capita...
13D/G signal
Venrock Healthcare Capita...
Evidence rows
15
Latest as of
30 Sep 2025
13D/G
3/4/5
13F
Lead comparable stake: 9.9%
13D/G row: Venrock Healthcare Capital Partners III, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Venrock Healthcare Capital Partners III, L.P. leads the comparable SEC ownership view at 9.9%.
Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Venrock Healthcare Capital Partne...
9.9%
FMR LLC
11%
Venrock Adviser, LLC
8.2%
Fairmount Funds Management LLC
6.7%
BlackRock, Inc.
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
3/4/5
10%+ Owner
|
9.9%
|
$94,411,973
4,909,619 shares
|
+$14,637,703 | 30 Sep 2025 |
| FMR LLC |
13F
Company
|
11%
|
$62,960,640
5,616,471 shares
|
— | 30 Jun 2025 |
| Venrock Adviser, LLC |
13F
Company
|
8.2%
|
$46,503,878
4,148,428 shares
|
— | 30 Jun 2025 |
| Fairmount Funds Management LLC |
3/4/5
13F
Director, 10%+ Owner · Company
|
6.7%
from 13F
|
$54,318,009
3,722,762 shares
mixed-class rows
|
— | 17 Sep 2025 |
| BlackRock, Inc. |
13F
Company
|
4%
|
$22,295,346
1,988,880 shares
|
— | 30 Jun 2025 |
| RTW INVESTMENTS, LP |
13F
Company
|
3.9%
|
$21,810,725
1,945,649 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
104
Shares
45,557,412
Rows available
104
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
81
Q3 2025 holders
104
Holder diff
23
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend